TVTX — TRAVERE THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 351 家机构在其最新 13F 申报中持有 TVTX(TRAVERE THERAPEUTICS INC),合计申报市值 $4.81B,对应 354.75M 股。按股数计算较上季度增持 12.0%(+28.07M 股),申报市值环比上升 84.9%。持仓集中度较高:前五大持有人占申报市值的 31.1%,前十大的集中度为 43.9%。
与上一季度相比,98 家新建仓位、128 家加仓、97 家减仓、34 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
TRAVERE THERAPEUTICS INC(TVTX)的主要机构持有人包括 Jupiter Topco LLC、Bank of America Corp、VANGUARD CAPITAL MANAGEMENT LLC,按 13F 申报市值在本页 573 家持有人中排名居前。
TVTX 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
持有 TVTX 的传奇投资人
我们追踪的超级投资人在各自最新 13F 申报中持有 TVTX 的名单——每位投资人按其自身最近一个季度展示。
| 投资人 | 季度 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|---|
|
|
Q3 2026 | 52.99K | $3.12M | 0.03% | 增持 |
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 269 | 238.43M | $2.36B | +14.2% |
| Q2 2026 | 351 | 354.75M | $4.81B | +12.0% |
| Q1 2026 | 286 | 246.15M | $2.24B | -2.4% |
| Q4 2025 | 304 | 236.70M | $3.36B | +41.0% |
| Q3 2025 | 266 | 166.61M | $2.02B | -18.9% |
| Q2 2025 | 234 | 246.62M | $1.34B | +35.1% |
| Q1 2025 | 242 | 192.56M | $9.41B | -22.5% |
| Q4 2024 | 214 | 233.78M | $9.39B | +27.9% |
表内 8 个季度中,机构持股合计增加 2%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(+41.0%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 8.88M | $131.36M | 2.33% | 持有 | |
| 5.99M | $88.72M | 0.00% | 增持 | |
| 5.10M | $75.44M | 0.10% | 增持 | |
| 3.48M | $51.55M | 0.00% | 减持 | |
| 2.78M | $41.20M | 0.07% | 增持 | |
| 41.67M | $39.75M | 1.11% | 增持 | |
| 2.50M | $36.93M | 0.05% | 减持 | |
| 2.09M | $30.95M | 1.13% | 增持 | |
| 2.00M | $29.66M | 0.00% | 增持 | |
| 1.91M | $28.24M | 1.76% | 减持 | |
| 1.57M | $23.21M | 0.00% | 减持 | |
| 1.56M | $23.04M | 0.01% | 增持 | |
| 1.54M | $22.80M | 2.46% | 减持 | |
| 21.11M | $20.90M | 1.51% | 持有 | |
| 20.39M | $19.67M | 0.56% | 增持 | |
| 1.32M | $19.46M | 1.79% | 增持 | |
| 1.19M | $17.68M | 0.01% | 减持 | |
| 1.15M | $17.02M | 0.29% | 持有 | |
| 1.14M | $16.89M | 1.03% | 增持 | |
| 1.13M | $16.74M | 0.04% | 减持 | |
| 1.13M | $16.74M | 0.01% | 减持 | |
| 1.10M | $16.33M | 0.03% | 增持 | |
| 1.06M | $15.65M | 0.03% | 增持 | |
| 1.00M | $14.83M | 0.59% | 新进 | |
| 918.71K | $13.60M | 0.03% | 增持 |
新建仓(Q2 2026)
- Jupiter Topco LLC 11.32M 股 · $643.30M
- GEODE CAPITAL MANAGEMENT, LLC 2.37M 股 · $134.77M
- Sixth Street Partners Management Company, L.P. 827.28K 股 · $47.00M
- Polar Asset Management Partners Inc. 30.50M 股 · $35.91M
- Point72 Asset Management 478.86K 股 · $27.20M
- Integral Health Asset Management, LLC 375.00K 股 · $21.30M
- Capricorn Fund Managers Ltd 321.72K 股 · $18.28M
- STEELHEAD PARTNERS LLC 15.00M 股 · $17.69M
- RAYMOND JAMES FINANCIAL INC 292.36K 股 · $16.61M
- SEB Asset Management AB 164.67K 股 · $9.36M
- DeepCurrents Investment Group LLC 7.30M 股 · $8.57M
- BlueCrest Capital Management Ltd 6.00M 股 · $7.08M
完全清仓(较上季)
- STATE STREET CORP 卖出 4.96M 股 · $147.36M
- RA CAPITAL MANAGEMENT, L.P. 卖出 746.84K 股 · $22.19M
- Soleus Capital Management, L.P. 卖出 546.00K 股 · $16.22M
- Janus Henderson Group 卖出 4.78M 股 · $6.04M
- KINGDON CAPITAL MANAGEMENT, L.L.C. 卖出 200.00K 股 · $5.94M
- Connor, Clark & Lunn Investment Management Ltd. 卖出 176.39K 股 · $5.24M
- Y-Intercept (Hong Kong) Ltd 卖出 117.36K 股 · $3.49M
- VOLORIDGE INVESTMENT MANAGEMENT, LLC 卖出 114.27K 股 · $3.39M
- SUPERSTRING CAPITAL MANAGEMENT LP 卖出 102.75K 股 · $3.05M
- FRED ALGER MANAGEMENT, LLC 卖出 86.24K 股 · $2.56M
- CAPITAL FUND MANAGEMENT S.A. 卖出 85.88K 股 · $2.55M
- PDT Partners, LLC 卖出 58.96K 股 · $1.75M
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 4.19M | 4.11M | 4.05M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.04M | 1.54M | 1.71M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 2.42M | 2.37M | 2.37M | 2.14M | 2.14M | 2.00M | 1.98M | 1.84M | 1.73M | 1.67M | 1.56M | 1.52M | 1.44M | 1.39M | 1.22M | 1.10M | 1.06M | 1.02M | 1.06M | 1.04M |
| Stephens Investment Management Group LLC | 1.88M | 1.88M | 1.80M | 1.72M | 1.60M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EMERALD ADVISERS, LLC | 1.56M | 1.60M | 1.56M | 1.59M | 2.15M | 2.09M | 2.08M | 2.13M | 1.96M | 1.64M | 1.75M | 1.05M | 1.06M | — | — | — | — | — | — | — |
| Context Capital Management, LLC | 62.70M | 50.50M | 52.93M | 57.46M | 46.35K | 8.00K | 8.00K | 8.00K | 56.82K | 60.74K | 61.02K | 53.39M | 41.17K | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 1.17M | 1.44M | 669.16K | 406.22K | 572.00K | 604.13K | 292.99K | 48.04K | — | — | 15.21K | 169.11K | — | — | — | — | — | — | — | — |
| Assenagon Asset Management S.A. | 1.15M | 427.31K | 7.93K | 417.74K | 93.36K | 1.10M | 413.51K | 530.51K | 1.37M | 2.21M | 218.68K | 254.05K | 254.05K | — | — | — | — | — | — | — |
| Renaissance Technologies | 1.08M | 1.83M | 1.97M | 2.25M | 1.75M | 2.50M | 2.70M | 2.41M | 1.88M | 2.20M | 2.86M | 3.08M | 1.99M | 1.56M | 2.14M | 1.59M | 1.51M | 1.66M | 1.36M | 1.04M |
| Nuveen, LLC | 1.08M | 1.05M | 938.57K | 993.61K | 1.08M | 1.19M | 1.20M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 54.27M | 50.73M | 4.97M | 3.67M | 3.17M | 3.17M | 3.25M | 3.62M | 2.73M | — | — | — | — | — | — | — | — | — | — | — |
| EMERALD MUTUAL FUND ADVISERS TRUST | 984.85K | 1.03M | 945.03K | 948.46K | 1.20M | 1.14M | 1.12M | 1.10M | 1.19M | 941.26K | 1.33M | 764.60K | 764.60K | — | — | — | — | — | — | — |
| Marshall Wace | 978.22K | 1.33M | 178.54K | 217.17K | 590.05K | 742.73K | — | — | 111.34K | — | — | — | 73.33K | — | 214.50K | — | — | — | — | 6.87K |
| BNP PARIBAS FINANCIAL MARKETS | 965.01K | 85.00K | 109.38K | 665.79K | 565.60K | 175.03K | 147.11K | 1.21M | — | — | — | — | — | — | — | — | — | — | — | — |
| Jones Hill Capital LP | 959.63K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Russell Investments Group, Ltd. | 778.34K | 395.97K | 234.26K | 285.31K | 222.26K | 1.04M | 1.04M | 467.00K | 161.27K | 166.06K | 184.62K | 103.01K | 97.51K | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 670.21K | 661.82K | 612.62K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| FULLER & THALER ASSET MANAGEMENT, INC. | 660.92K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fiera Capital Corp | 555.59K | 517.00K | 900.87K | 874.05K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PANAGORA ASSET MANAGEMENT INC | 543.11K | 490.72K | 592.91K | 587.35K | 569.70K | 432.02K | 335.96K | 335.16K | 320.33K | 90.88K | — | 84.91K | 252.30K | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold TVTX?
As of 2026-Q2, 351 institutional funds reported holding TVTX (TRAVERE THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $4.81B.
How many shares of TVTX do institutions own?
13F filers reported 354.75M shares of TVTX, worth $4.81B in aggregate at the end of 2026-Q2.
Is institutional ownership of TVTX rising or falling?
Share counts moved +12.0% versus the prior quarter — accumulation.
Who are the top institutional holders of TVTX?
The largest 13F holders are Jupiter Topco LLC, Bank of America Corp, VANGUARD CAPITAL MANAGEMENT LLC, Vanguard Group, PERCEPTIVE ADVISORS LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of TRAVERE THERAPEUTICS INC?
The major shareholders of TRAVERE THERAPEUTICS INC (TVTX) by reported 13F value are Jupiter Topco LLC, Bank of America Corp, VANGUARD CAPITAL MANAGEMENT LLC, Vanguard Group, PERCEPTIVE ADVISORS LLC, among 573 institutional holders.
Which legendary investors own TVTX?
1 of the legendary investors tracked on HoldingsHub report TVTX (TRAVERE THERAPEUTICS INC) in their latest 13F filings, led by Polen Capital Management. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on TVTX?
1 tracked superinvestors hold TVTX simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.